Ken Griffin acquired 246k Beam Therapeutics shares worth $5.14M. That's 0.00% of their equity portfolio (1820th largest holding). The first Beam Therapeutics trade was made in Q1 2020. Since then Ken Griffin bought shares 36 more times and sold shares on twenty occasions. The investor's estimated purchase price is $10.9M, resulting in a loss of 53%.